Search Results
HER2DX and pCR in HER2-positive breast cancer: a combined analysis of 4 neoadjuvant studies
HER2-E pCR with anti-HER2-based neoadjuvant therapies
Independent validation of the HER2DX genomic test in HER2-positive breast cancer
EA1181/CompassHER2 pCR Research Study for HER2-Positive Breast Cancer - Full Video
Dr. O’Regan on Prognostic Value of pCR in HER2+ Breast Cancer
HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer
Overview of Neoadjuvant Therapy in HER2+ Breast Cancer
CompassHER2-pCR: de-escalation of neoadjuvant chemotherapy for breast cancer
Dr. Hamilton on Using pCR to Classify Risk in HER2+ Breast Cancer
HER2DX risk-score in early-stage HER2-positive breast cancer
Dr. Han on the Importance of pCR in Breast Cancer
Optimizing adjuvant treatment in HR+/HER2- early breast cancer
